CYFUSE BIOMEDICAL K K financial statements, including revenue, expenses, profit, and loss
The total revenue of 4892 for the last quarter is 31.38 M JPY, and it's 173.92% higher compared to the previous quarter. The net income of Q4 23 is -54.63 M JPY.